About Jeffrey W. Strovel

Scientific leader experienced in basic, preclinical, and clinical development of therapies targeting cancer. Senior member of clinical development team formed to identify and validate biomarkers to advance lead candidates through pre-clinical toxicology and early clinical studies. Demonstrated ability to lead successful programs in small molecule drug discovery and development including drug target identification, Hit to Lead nomination, and Drug lead optimization

Specialties: • Proven leader/mentor and creative cancer biologist.
• Broad knowledge in Drug Discovery/Development process, issues, and solutions.
• Extensive expertise in biomarker discovery and application in oncology drug development.
• Demonstrated ability to design and execute innovative strategies for drug lead optimization and mechanism of action studies.
• Expertise in data analysis using diverse bioinformatics tools for preclinical and clinical applications.